CareDx, Inc. (CDNA) financials: revenue, earnings and cash flow
Fiscal 2017–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
CareDx’s revenue went from $48M in fiscal 2017 to $380M in fiscal 2025, growth of about 29.4% a year.
Net income in fiscal 2025 was -$21M, a net margin of -5.6%; the best year in this period was 2024 with $53M.
Over the twelve months to September 30, 2026, revenue was $497M and net income $129M.
The diluted share count rose 128% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $497M | $380M | $334M | $280M | $322M | $296M | $192M | $127M | $77M | $48M |
| Gross profit | — | — | — | — | — | — | — | $82M | $44M | $27M |
| Operating income | $116M | -$31M | $41M | -$203M | -$77M | -$30M | -$23M | -$25M | -$16M | -$20M |
| Net income | $129M | -$21M | $53M | -$190M | -$77M | -$31M | -$19M | -$22M | -$47M | -$55M |
| EPS (diluted) | $2.39 | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 |
| R&D | $84M | $71M | $73M | $82M | $90M | $77M | $49M | $31M | $15M | $12M |
| Revenue growth | — | +13.8% | +19.1% | −12.9% | +8.6% | +54.2% | +51.2% | +66.0% | +58.5% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $69M | $42M | $38M | -$18M | -$25M | -$19M | $33M | -$3M | -$4M | -$14M |
| Capital spending | -$9M | — | — | — | — | — | — | — | -$2M | -$186000 |
| Free cash flow | $60M | — | — | — | — | — | — | — | -$6M | -$14M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $24M | $88M | $522000 | $28M | $642000 | $0 | $0 | — | — | — |
| Stock-based pay | $38M | $35M | $66M | $49M | $47M | $36M | $23M | $22M | $7M | $2M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $177M | $261M | $235M | $293M | $348M | $225M | $38M | $65M | $17M |
| Debt | — | $26M | $28M | $34M | $39M | $21M | $18M | $5M | $0 | $34M |
| Equity | — | $303M | $378M | $261M | $431M | $466M | $278M | $99M | $96M | -$6M |
| Total assets | — | $413M | $491M | $467M | $543M | $567M | $369M | $152M | $131M | $84M |
| Shares (diluted) | 55M | 53M | 57M | 54M | 53M | 52M | 46M | 42M | 36M | 23M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | 64.2% | 56.9% | 55.8% |
| Operating margin | 23.4% | -8.1% | 12.2% | -72.5% | -24.0% | -10.0% | -11.7% | -19.3% | -20.3% | -42.0% |
| Net margin | 25.9% | -5.6% | 15.7% | -67.9% | -23.8% | -10.3% | -9.7% | -17.3% | -61.1% | -114.8% |
| FCF margin | 12.0% | — | — | — | — | — | — | — | -7.9% | -30.0% |
| ROIC | — | -7.4% | 10.0% | -54.4% | -13.0% | -5.8% | -7.2% | -21.6% | -15.8% | -70.5% |
| ROE | — | -7.0% | 13.9% | -72.8% | -17.8% | -6.6% | -6.7% | -22.2% | -48.7% | 904.3% |
Frequently asked questions
What is CareDx’s annual revenue?
$380M in fiscal 2025 and $497M over the twelve months to September 30, 2026.
How much profit does CareDx make?
Net income was -$21M in fiscal 2025 (net margin -5.6%).
Is CareDx’s revenue growing?
Yes: revenue rose 13.8% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.